U.S. Markets

BROKER MOVES: MRNA upgraded at Argus; ALL downgraded at Argus

StockNow breaking-news AI analysis

Broker actions include Argus upgrading Moderna to Buy with a USD 180 price target and downgrading Allstate to Hold, alongside multiple other rating changes across Wall Street.

News detail

UPGRADES Baozun (BZUN) Upgraded from Hold to Outperform at CLSA; PT USD 3.80 Evolution Petroleum (EPM) Upgraded from Market Perform to Outperform at Northland Element Solutions (ESI) Upgraded from Hold to Buy at Freedom Broker; PT USD 48 Moderna (MRNA) Upgraded from Hold to Buy at Argus; PT USD 180 Petrobras (PBR) Upgraded from Neutral to Outperform at Bradesco BBI; PT USD 20 DOWNGRADES Allstate (ALL) Downgraded from Buy to Hold at Argus VTEX (VTEX) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 4 Workday (WDAY) Downgraded from Overweight to Equal-weight at Capital One; PT USD 219 INITIATIONS CV (CV) Initiated at Buy at Roth; PT USD 9 Overseas Shipholding Group (OSG) Initiated at Outperform at Keefe, Bruyette & Woods; PT USD 8 TeraWulf (WULF) Initiated at Outperform at William Blair

9 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more